Second-generation antipsychotics in the treatment of major depressive disorder: current evidence

Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants

(2016) Robert M. Berman et al.   CNS SPECTRUMS

Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data

(2014) Anna Wesołowska   Pharmacological Reports

Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials

(2012) Narong Maneeton et al.   BMC Psychiatry

EXTENDED RELEASE QUETIAPINE FUMARATE IN MAJOR DEPRESSIVE DISORDER: ANALYSIS IN PATIENTS WITH ANXIOUS DEPRESSION

(2012) Michael E. Thase et al.   DEPRESSION AND ANXIETY

Iloperidone, asenapine and lurasidone: a primer on their current status

(2012) Frank I Tarazi et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy

(2012) James Craig Nelson et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

(2012) George I. Papakostas et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Effect of Initial Duloxetine Dosing Strategy on Nausea in Korean Patients with Major Depressive Disorder

(2012) Min-Soo Lee et al.   Psychiatry Investigation

A Comparative Study on Alexithymia in Depressive, Somatoform, Anxiety, and Psychotic Disorders among Koreans

(2012) Sung hwa Son et al.   Psychiatry Investigation

Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report

(2012) Young-Min Park et al.   Psychiatry Investigation

Development and Validation of a Screening Scale for Depression in Korea: The Lee and Rhee Depression Scale

(2012) Seon Hee Hwang et al.   Psychiatry Investigation

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

(2012) Maurizio Fava et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

(2011) A. John Rush et al.   AMERICAN JOURNAL OF PSYCHIATRY

Do we need more than one antidepressant for patients with major depressive disorder?

(2011) Chi-Un Pae et al.   Expert Review of Neurotherapeutics

Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder

(2011) Richard H. Weisler et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy of Dose Increase Among Nonresponders to Low-Dose Aripiprazole Augmentation in Patients With Inadequate Response to Antidepressant Treatment:

(2011) David Mischoulon et al.   JOURNAL OF CLINICAL PSYCHIATRY

Paliperidone Augmentation for Treatment-Resistant Depression

(2011) Fei-Wen Yang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Adjunctive Low-Dose Aripiprazole With Standard-Dose Sertraline in Treating Fresh Major Depressive Disorder

(2011) Chien-Ho Lin et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The Effectiveness and Safety of Adjunctive Aripiprazole in Taiwanese Patients With Antidepressant-Refractory Major Depressive Disorder

(2011) Shaw-Ji Chen et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Treating Depression After Initial Treatment Failure

(2011) Bradley N. Gaynes et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The Symptom Frequency Characteristics of the Hamilton Depression Rating Scale and Possible Symptom Clusters of Depressive Disorders in Korea: The CRESCEND Study

(2011) Sae-Heon Jang et al.   Psychiatry Investigation

Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report

(2011) A. J. Rush et al.   PSYCHOLOGICAL MEDICINE

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

(2011) Robert Berman et al.   Neuropsychiatric Disease and Treatment

The Association between Conventional Antidepressants and the Metabolic Syndrome

(2010) Roger S. McIntyre et al.   CNS DRUGS

Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder

(2010) Chi-Un Pae et al.   CNS DRUGS

Second-generation antipsychotics in major depressive disorder: update and clinical perspective

(2010) Jun Chen et al.   CURRENT OPINION IN PSYCHIATRY

Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial

(2010) Michael Liebowitz et al.   DEPRESSION AND ANXIETY

Therapeutic potential of new second generation antipsychotics for major depressive disorder

(2010) Susan L McElroy et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis

(2010) David C. Steffens et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

(2010) Nizar El-Khalili et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆

(2010) Brian Bortnick et al.   JOURNAL OF AFFECTIVE DISORDERS

Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression

(2010) Mauricio Tohen et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Pooled MADRS/IDS Cross-Correlation Analysis

(2010) Frederick W. Reimherr et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Pilot, 8-Week, Placebo Lead-In Trial of Quetiapine Extended Release for Depression in Midlife Women

(2010) Claudio N. Soares et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Quetiapine XR: Current status for the treatment of major depressive disorder

(2010) Chi-Un Pae et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine

(2009) J. Wijkstra et al.   ACTA PSYCHIATRICA SCANDINAVICA

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

(2009) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic Depression

(2009) Barnett S. Meyers   ARCHIVES OF GENERAL PSYCHIATRY

Effectiveness Study of Venlafaxine-XR Combined with Aripiprazole for Chronic or Recurrent Major Depressive Disorder

(2009) Andrew A. Nierenberg et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder

(2009) Amir Garakani et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning

(2009) Madhukar H. Trivedi et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: An open-label, pilot study

(2009) I.M. Anderson et al.   JOURNAL OF AFFECTIVE DISORDERS

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.

(2009) Raymond W. Lam et al.   JOURNAL OF AFFECTIVE DISORDERS

Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: A post-hoc, pooled analysis of two large, placebo-controlled studies

(2009) J. Craig Nelson et al.   JOURNAL OF AFFECTIVE DISORDERS

Adjunctive Aripiprazole in Major Depressive Disorder

(2009) Madhukar H. Trivedi et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder

(2009) Hollis Reeves et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY

An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression

(2009) Madhukar H. Trivedi et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder

(2009) Andrew J. Cutler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antipsychotic-Induced Extrapyramidal Side Effects in Bipolar Disorder and Schizophrenia

(2009) Keming Gao et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Metabolic Assessment of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

(2009) Maurizio Fava et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report

(2009) A. A. Nierenberg et al.   PSYCHOLOGICAL MEDICINE

The 5-HT7 receptor and disorders of the nervous system: an overview

(2009) Peter B. Hedlund   PSYCHOPHARMACOLOGY

The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial

(2008) Yves Chaput et al.   BMC Psychiatry

Aripiprazole in the Treatment of Depressive and Anxiety Disorders

(2008) Chi-Un Pae et al.   CNS DRUGS

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD

(2008) George I. Papakostas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

What predicts attrition in second step medication treatments for depression?: a STAR*D Report

(2008) Diane Warden et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

(2008) Gabor I. Keitner et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

(2008) IM Anderson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression

(2007) George S. Alexopoulos et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Aripiprazole as an adjunctive treatment for refractory unipolar depression

(2007) David J. Hellerstein et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY